First-In-Human Intrathecal Gene Transfer Study for Giant Axonal Neuropathy: Three-Year Study Review of Safety, Immunologic Responses and Interim Analysis of Efficacy

被引：0
|
作者：
Bharucha-Goebel, D.
Saade, D.
Jain, M.
Waite, M.
Norato, G.
Cheung, K.
Foley, A. R.
Soldatos, A.
Rybin, D.
Lehky, T.
Del Hoyo, Calcedo R.
Jacobson, S.
Samulski, R. J.
Gray, S.
Bonnemann, C.
机构：
来源：
ANNALS OF NEUROLOGY | 2019年 / 86卷
关键词：
Neuromuscular Disorders; Translational/Experimental Therapeutics; Genetics;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
260
引用
收藏
页码：S168 / S168
页数：1
相关论文
共 24 条
  • [11] Immune Analysis Following Intrathecal Gene Transfer: 3-Year Data from Clinical Intrathecal Gene Transfer Trial for Patients with Giant Axonal Neuropathy
    Bharucha-Goebel, Diana
    Saade, Dimah
    Soldatos, Ariane
    Kang, Elizabeth
    Del Calcedo, Roberto
    Hu, Ying
    Leibovitch, Emily
    Jacobson, Steven
    Rybin, Denis
    Foley, A. Reghan
    Gray, Steven
    Bonnemann, Carsten
    MOLECULAR THERAPY, 2019, 27 (04) : 298 - 299
  • [12] A Systematic Analysis of the Immunologic Effects of Intrathecal AAV9 Mediated Gene Transfer Targeting the Nervous System in Giant Axonal Neuropathy
    Bharucha-Goebel, Diana
    Saade, Dimah
    Kang, Elizabeth
    Chichester, Jessica
    Del Hoyo, Roberto Calcedo
    Hu, Ying
    Soldatos, Ariane
    Monaco-Kushner, Maria
    Akahata, Yoshimi
    Jacobson, Steve
    Foley, A. Reghan
    Gray, Steve
    Bonnemann, Carsten
    MOLECULAR THERAPY, 2020, 28 (04) : 24 - 25
  • [13] Interim Review of Safety, Tolerability, and Efficacy From a First-In-Human Phase 1/2a Clinical Study of ICM-203, an Intra-Articular, AAV Gene Therapy for Osteoarthritis
    Heald, Alison E.
    Solomon, Bogdan
    Page, Richard
    Ahn, Yoenhee
    Yum, Young Na
    Myung, Jayhyuk
    Collins, Jamie E.
    Guermazi, Ali
    Kim, Dae-Won
    MOLECULAR THERAPY, 2024, 32 (04) : 80 - 80
  • [14] Percutaneous Ventricular Restoration Using the Parachute Device in Patients With Ischemic Heart Failure Three-Year Outcomes of the PARACHUTE First-in-Human Study
    Costa, Marco A.
    Mazzaferri, Ernest L.
    Sievert, Horst
    Abraham, William T.
    CIRCULATION-HEART FAILURE, 2014, 7 (05) : 752 - 758
  • [15] Long-term efficacy and safety of perampanel as a first add-on therapy in patients with focal epilepsy: Three-year extension study
    Im, Kayeong
    Lee, Sang-Ahm
    Kim, Ji Hyun
    Kim, Dong Wook
    Lee, Sang Kun
    Seo, Dae Won
    Lee, Ji Woong
    EPILEPSY & BEHAVIOR, 2021, 125
  • [16] RGX-121: An Investigational Gene Therapy for the Treatment of Neuronopathic Mucopolysaccharidosis Type II (MPSII): Interim Analysis from the First-in-Human Study
    Pisani, L.
    Ficicioglu, C.
    Giugliani, R.
    Harmatz, P.
    Rajan, D.
    Hagood, J.
    Fiscella, M.
    Yang, L.
    Wang, H.
    Gilmor, M.
    Cho, Y.
    Mulatya, C.
    Phillips, D.
    Falabella, P.
    ANNALS OF NEUROLOGY, 2023, 94 : S67 - S68
  • [17] RGX-111: An Investigational Gene Therapy for the Treatment of Severe Mucopolysaccharidosis Type I (MPS I): Interim Analysis from the First-in-Human Study
    Pisani, L.
    Wang, R.
    Ficicioglu, C.
    Giugliani, R.
    Burke, J.
    Yang, L.
    Wang, H.
    Gilmor, M.
    Cho, Y.
    Mulatya, C.
    Phillips, D.
    Falabella, P.
    ANNALS OF NEUROLOGY, 2023, 94 : S68 - S68
  • [18] A SAFETY AND EFFICACY STUDY OF NOVOTTF-100A FOR PEDIATRIC HIGH-GRADE GLIOMA: RESULTS OF THE PLANNED INTERIM ANALYSIS OF THE FIRST THREE CASES
    Makimoto, Atsushi
    Terashima, Keita
    Nishikawa, Ryo
    Fujisaki, Hiroyuki
    Kurihara, Jun
    Ihara, Satoshi
    Adachi, Jun-ichi
    Enokizono, Mikako
    Morikawa, Yoshihiko
    Yuza, Yuki
    NEURO-ONCOLOGY, 2023, 25
  • [19] RGX-121: AN INVESTIGATIONAL GENE THERAPY FOR THE TREATMENT OF NEURONOPATHIC MUCOPOLYSACCHARIDOSIS TYPE II (MPS II): INTERIM ANALYSIS OF DATA FROM THE FIRST-IN-HUMAN STUDY
    Blair, D. R.
    Harmatz, P.
    Ficicioglu, C.
    Giugliani, R.
    Rajan, D. S.
    Hagood, J.
    Fiscella, M.
    Yang, L.
    Gilmor, M.
    Cho, Y.
    Mulatya, C.
    Phillips, D.
    Falabella, P.
    Pisani, L.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2024, 72 (01) : 638 - 638
  • [20] Interim Safety, Efficacy and Achievement of Developmental Milestones in this Phase 1, First-In-Human Study of the Systemic Delivery of AVXS-101, an AAV9-Mediated Gene Therapy for Children with Spinal Muscular Atrophy (SMA) Type 1
    Sproule, D.
    Al-Zaidy, S.
    Shell, R.
    Arnold, D.
    Rodino-Klapac, L.
    Kissel, J.
    Prior, T.
    Miranda, C.
    Lowes, L.
    Alfano, L.
    Berry, K.
    Nagendran, S.
    Cardenas, J.
    Petek, C.
    Church, K.
    Burghes, A.
    Foust, K.
    Meyer, K.
    Likhite, S.
    Kaspar, B.
    Mendell, J.
    ANNALS OF NEUROLOGY, 2016, 80 : S367 - S367
123